Cardiovascular Changes and Tetracaine Pharmacokinetics Following Intranasal Administration of Standard and High Doses of Kovacaine Mist (Tetracaine Hydrochloride With Oxymetazoline Hydrochloride) in Healthy Volunteers.

Trial Profile

Cardiovascular Changes and Tetracaine Pharmacokinetics Following Intranasal Administration of Standard and High Doses of Kovacaine Mist (Tetracaine Hydrochloride With Oxymetazoline Hydrochloride) in Healthy Volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jul 2016

At a glance

  • Drugs Oxymetazoline/tetracaine (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors St. Renatus
  • Most Recent Events

    • 19 Jul 2016 Results of population pharmacokinetics of two phase II studies including this study published in the Journal of Clinical Pharmacology
    • 06 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top